Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	71.58	188.89	34.86	15.14	90.1	19.25
Short-Term Investments	342.65	150.38	20.85	77.99	56.18	52.7
Cash & Short-Term Investments	414.23	339.28	55.71	93.13	146.27	71.95
Cash Growth	103.45%	508.99%	-40.18%	-36.33%	103.30%	-3.44%
Other Receivables	1.7	-	0.38	0.82	-	-
Receivables	1.7	-	0.38	0.82	-	-
Prepaid Expenses	5.15	2.25	6.17	4.95	3.52	2.56
Total Current Assets	421.08	341.53	62.26	98.89	149.79	74.51
Property, Plant & Equipment	-	-	7.25	9.15	9.94	7.17
Other Long-Term Assets	0.01	0.33	1.64	1.88	1.89	1.51
Total Assets	421.09	341.86	71.14	109.93	161.62	83.18
Accounts Payable	5.17	0.9	0.68	3.32	2.25	3.15
Accrued Expenses	14.65	29.69	12.82	13.25	13.41	14.39
Current Portion of Leases	-	-	0.64	0.85	0.35	0.38
Current Unearned Revenue	-	-	0.52	2.36	-	-
Other Current Liabilities	37.72	1.39	-	0.37	0.44	0.44
Total Current Liabilities	57.54	31.98	14.66	20.14	16.44	18.36
Long-Term Leases	-	-	4	4.62	5.17	4.74
Long-Term Unearned Revenue	-	-	2.18	1.22	-	-
Other Long-Term Liabilities	36.16	125.87	-	-	0.17	-
Total Liabilities	93.7	157.84	20.84	25.99	21.79	23.1
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,086	763.19	475.97	425.77	415.82	255.14
Retained Earnings	-916.14	-764.41	-425.62	-341.81	-276.01	-195.12
Comprehensive Income & Other	1.46	0.3	-0.05	-0.02	0.01	0.05
Total Common Equity	171.57	-0.91	50.31	83.94	139.83	60.08
Shareholders' Equity	327.39	184.02	50.31	83.94	139.83	60.08
Total Liabilities & Equity	421.09	341.86	71.14	109.93	161.62	83.18
Total Debt	-	-	4.65	5.48	5.52	5.12
Net Cash (Debt)	414.23	339.28	51.07	87.65	140.75	66.83
Net Cash Growth	103.45%	564.39%	-41.74%	-37.73%	110.62%	-10.31%
Net Cash Per Share	11.16	49.19	15.15	33.33	65.93	52.29
Filing Date Shares Outstanding	51.43	36.15	2.62	1.97	1.92	1.16
Total Common Shares Outstanding	51.4	36.06	2.61	1.97	1.92	1.16
Working Capital	363.54	309.55	47.6	78.75	133.35	56.15
Book Value Per Share	3.34	-0.03	19.24	42.52	72.89	51.64
Tangible Book Value	171.57	-0.91	50.31	83.94	139.83	60.08
Tangible Book Value Per Share	3.34	-0.03	19.24	42.52	72.89	51.64
Machinery	-	-	2.85	2.82	2.72	1.53
Leasehold Improvements	-	-	4.39	4.39	4.77	1.81

Source: S&P Capital IQ. Standard template. Financial Sources.